Subscribe To
Olympic steel, inc. (zeus) q4 2022 earnings call transcript
Olympic Steel, Inc. (NASDAQ:ZEUS ) Q4 2022 Earnings Conference Call February 24, 2023 10:00 AM ET Company Participants Rich Manson - Chief Financial O...
February 24, 2023, 12:12 pm
Kinnate biopharma inc. receives fast track designation from the u.s. food and drug administration for kin-3248, an investigational pan-fgfr inhibitor
SAN FRANCISCO and SAN DIEGO, Feb. 14, 2023 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision onco...
February 14, 2023, 9:05 pm
Aravive to present positive updated data from phase 1b trial of batiraxcept in combination with cabozantinib for treatment of clear cell renal cell carcinoma at the 2023 asco genitourinary (gu) cancer
HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted...
February 13, 2023, 5:00 pm
Aravive to present positive updated data from phase 1b trial of batiraxcept in combination with cabozantinib for treatment of clear cell renal cell carcinoma at the 2023 asco genitourinary (gu) cancer
HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted...
February 13, 2023, 5:00 pm
Aravive to present positive updated data from phase 1b trial of batiraxcept in combination with cabozantinib for treatment of clear cell renal cell carcinoma at the 2023 asco genitourinary (gu) cancer
HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted...
February 13, 2023, 5:00 pm
Cinemark to participate in morgan stanley investor conference
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest motion picture exhibito...
February 13, 2023, 4:34 pm
Verona pharma: small biotech targeting $10bn copd market with a late stage drug
Verona Pharma is a UK-based biotech with a $1.6Bn market cap developing a phase 3 asset targeting COPD. Ensifentrine is a novel phase 3 inhaled select...
February 7, 2023, 6:01 am
Kalvista pharmaceuticals to present at svb securities global biopharma conference
CAMBRIDGE, Mass. & SALISBURY, England--( BUSINESS WIRE )--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focus...
February 3, 2023, 6:30 am
The reasons why the bito etf could be a safer approach to bitcoin
The FTX bankruptcy may have thawed the crypto winter. Bitcoin makes significant gains after its implosive move....
February 2, 2023, 4:55 pm
Deluxe corporation (dlx) q4 2022 earnings call transcript
Deluxe Corporation (NYSE:DLX ) Q4 2022 Earnings Conference Call February 2, 2023 8:30 AM ET Company Participants Thomas Mora...
February 2, 2023, 11:31 am
Gsk chronic kidney disease drug receives green light
The US Food and Drug Administration (FDA) has given the green light to Jesduvroq, an oral hypoxia-inducible factor prolyl hydroxylase inhi...
February 2, 2023, 5:58 am
Onl therapeutics receives u.s. fda clearance of investigational new drug application for onl1204 ophthalmic solution
First-in-class small molecule Fas inhibitor with unique mechanism of action is designed to provide neur...
February 1, 2023, 12:00 pm
Highlights from ifx expo dubai 2023 – throwback to the largest mena fintech gathering
iFX EXPO Dubai 2023 was a resounding success in the financial and fintech space, attracting over 3500 attendees and over 120 indu...
January 31, 2023, 8:37 am
bito: playing bitcoin’s big 2023 rally
Crypto felt left for dead toward the end of 2022 amid weak price action and the FTX saga. Find out why I’m bullish on the ...
January 31, 2023, 12:59 am
bito: playing bitcoin's big 2023 rally
Crypto felt left for dead toward the end of 2022 amid weak price action and the FTX saga. Buyers have stepped in the near year, with both spot Bitcoin...
January 30, 2023, 7:26 pm
Effector therapeutics to present at 2023 bio ceo & investor conference
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the developme...
January 30, 2023, 8:00 am
Apellis: empaveli ought to win approval for eye disease in february - the future looks bright
Apellis has successfully guided its C3 complement inhibitor Pegcetacoplan to an approval in paroxysmal ...
January 27, 2023, 12:29 pm
Finance magnates africa summit: opportunities for sponsors & exhibitors
The Finance Magnates Africa Summit (FMAS:23) is coming to South Africa this May, showcasing one of the fastest growing markets in...
January 26, 2023, 3:01 pm
Kymera: data derisks platform, but i will wait for more
Kymera Therapeutics, Inc.'s KT-474 HS/AD data de-risked the IRAK4 protein degradation platform, as did Sanofi's partnering. However, more differentiat...
January 23, 2023, 6:58 pm
Cti biopharma: limited cash runway, but better than expected commercial launch
CTI BioPharma has reported a better-than-expected Q3 print of 18.5M, which is a 40% growth QoQ, and we expect this growth to continue reaching close t...
January 20, 2023, 7:54 am